Harvard Bioscience, Inc. (HBIO): Price and Financial Metrics

Harvard Bioscience, Inc. (HBIO): $3.30

0.03 (+0.92%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

HBIO Price/Volume Stats

Current price $3.30 52-week high $6.20
Prev. close $3.27 52-week low $3.25
Day low $3.25 Volume 87,398
Day high $3.46 Avg. volume 87,148
50-day MA $3.95 Dividend yield N/A
200-day MA $4.34 Market Cap 143.32M

HBIO Stock Price Chart Interactive Chart >


Harvard Bioscience, Inc. (HBIO) Company Bio


Harvard Bioscience, Inc. develops, manufactures, and markets scientific instruments, systems, and lab consumables used in life science research. The company was founded in 1901 and is based in Holliston, Massachusetts.


HBIO Latest News Stream


Event/Time News Detail
Loading, please wait...

HBIO Latest Social Stream


Loading social stream, please wait...

View Full HBIO Social Stream

Latest HBIO News From Around the Web

Below are the latest news stories about HARVARD BIOSCIENCE INC that investors may wish to consider to help them evaluate HBIO as an investment opportunity.

Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023

HOLLISTON, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced it will be presenting at the Benchmark Company 12th Annual Discovery One-on-One Investor Conference to be held Thursday December 7th, 2023 at the New York Athletic Club in New York City. The conference offers emerging growth and dynamic publicly traded companies access to institutional and individual investors in a unique one-on-one format during which Jim Green, Chairman and Chief Executi

Yahoo | November 20, 2023

With 60% ownership, Harvard Bioscience, Inc. (NASDAQ:HBIO) boasts of strong institutional backing

Key Insights Significantly high institutional ownership implies Harvard Bioscience's stock price is sensitive to their...

Yahoo | November 20, 2023

Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023

HOLLISTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Southwest IDEAS Investor Conference on Thursday November 16, 2023 at The Statler in Dallas, Texas. Joining him will be Jennifer Cote, the company’s Chief Financial Officer and Treasurer. The Company’s presentation will begin at 9:40 AM ET / 8:40 AM CT on November 16th. A replay of the presentation will be

Yahoo | November 9, 2023

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2023 Earnings Call Transcript

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2023 Earnings Call Transcript November 7, 2023 Harvard Bioscience, Inc. misses on earnings expectations. Reported EPS is $0.01 EPS, expectations were $0.04. Operator: Thank you for standing by and welcome to the Harvard Biosciences Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, today’s program is being recorded. […]

Yahoo | November 9, 2023

Q3 2023 Harvard Bioscience Inc Earnings Call

Q3 2023 Harvard Bioscience Inc Earnings Call

Yahoo | November 8, 2023

Read More 'HBIO' Stories Here

HBIO Price Returns

1-mo -10.81%
3-mo -25.00%
6-mo -29.18%
1-year -41.90%
3-year -53.85%
5-year 42.86%
YTD -38.32%
2023 93.14%
2022 -60.71%
2021 64.34%
2020 40.66%
2019 -4.09%

Continue Researching HBIO

Want to see what other sources are saying about Harvard Bioscience Inc's financials and stock price? Try the links below:

Harvard Bioscience Inc (HBIO) Stock Price | Nasdaq
Harvard Bioscience Inc (HBIO) Stock Quote, History and News - Yahoo Finance
Harvard Bioscience Inc (HBIO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!